Medicus Pharma Ltd

MDCX

Healthcare Drug Manufacturers General

EPS
+51.2%
Free cash flow
−27.7%

Quarter to June 2026, against a year earlier

1.87 0.04 +2.19%
Market cap
$3.5M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
Net debt / EBITDA
0.3×
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22
Current Ratio
1.00 2.33 2.42 0.02
Net Debt/EBITDA
0.25 0.37 0.36 0.27
Debt/Equity
0.00 0.00 0.00 0.00
ROE
(2,981.87%) (525.45%) 95.88% 0.00%
ROA
(602.13%) (295.90%) (488.54%) 0.00%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
99,562.95% (363.12%) (478.16%) 13.87%
Free Cash Flow per Share
(65.89) (53.26) (59.75) (14.02)
Book value per Share
0.11 16.29 15.97 (161.78)
Free Cash Flow
(22.78) (10.25) (4.16) (1.06)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026